RTW Biotech Opportunities (LON:RTW – Get Free Report)’s stock price was up 1.7% during trading on Tuesday. The stock traded as high as GBX 2.37 and last traded at GBX 2.37. 660,803 shares changed hands during mid-day trading, an increase of 3% from the average session volume of 639,478 shares. The stock had previously closed at GBX 2.33.
RTW Biotech Opportunities Trading Up 0.8%
The business has a fifty day simple moving average of GBX 2.38 and a 200 day simple moving average of GBX 2.25. The company has a debt-to-equity ratio of 22.80, a quick ratio of 0.81 and a current ratio of 0.26. The company has a market cap of £7.88 million, a P/E ratio of 0.04 and a beta of 0.78.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Featured Articles
- Five stocks we like better than RTW Biotech Opportunities
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
